Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.32 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ESRRA | P11474 | 1/20 | 0.31 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31651454 | 0.93 | MAPK14 (0.34) | MAPK14VCAM1NPC1RAB9AKDM4E | |
| SCHEMBL21586961 | 0.88 | FDPS (0.36) | MAPK14 | |
| SCHEMBL23636572 | 0.87 | VCAM1 (0.33) | VCAM1 | |
| SCHEMBL21586965 | 0.87 | NPC1 (0.40) | ACSS2VCAM1NPC1RAB9AKDM4E | |
| SCHEMBL23636568 | 0.86 | PTGS2 (0.33) | VCAM1 | |
| SCHEMBL8040102 | 0.85 | NPC1 (0.32) | NPC1RAB9AEGLN2EGLN1LMNA | |
| SCHEMBL23638712 | 0.83 | NPC1 (0.37) | ACSS2VCAM1NPC1RAB9AKDM4E | |
| SCHEMBL23636580 | 0.83 | VCAM1 (0.33) | VCAM1 | |
| SCHEMBL21586947 | 0.82 | PDE2A (0.36) | ACSS2VCAM1NPC1RAB9AKDM4E | |
| SCHEMBL8441278 | 0.82 | CA1 (0.39) | ACSS2NPC1RAB9ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250216700-A1 | REACTIVE UV ABSORBERS AND ANTI-BLUE LIGHT EYE DEVICE COMPRISING THE SAME | EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) | 2025-07-03 | — | — | US | disclosed |
| EP-3578550-B1 | NOVEL RED-SHIFTING BENZOTRIAZOLE UV ABSORBERS | EVERLIGHT CHEM IND CORP (TW) | 2023-08-16 | — | — | EP | disclosed |
| EP-3578550-A1 | NOVEL BENZOTRIAZOLE UV ABSORBER WITH RED SHIFT AND USE THEREOF | Everlight Chemical Industrial Corporation (TW) | 2019-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250216700-A1 | REACTIVE UV ABSORBERS AND ANTI-BLUE LIGHT EYE DEVICE COMPRISING THE SAME | UACA, IK, CRY2 | ACSS2 2654/4885MAPK14 3276/4885VCAM1 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.